Why the Rise of AI as a Non‑Judgmental Doctor Raises Complex Issues of Liability, Regulation, and Privacy in India
A noticeable shift is occurring in the Indian health‑seeking behaviour whereby individuals are increasingly seeking medical guidance from artificial intelligence platforms that are being described as a doctor who does not judge them. Patients appear to value the perceived absence of personal bias, stigma, or judgment in these AI systems, leading them to rely on algorithmic recommendations for diagnosing conditions, suggesting treatments, or monitoring health parameters. The trend is being highlighted under the headline phrase “a doctor who doesn’t judge”, emphasizing the emotional comfort some users report when interacting with non‑human medical advisors compared with traditional practitioner encounters. While the technological capabilities of these AI tools vary widely, the overarching perception among users is that the digital interface provides a neutral, evidence‑based source of information that does not involve personal judgment or moral appraisal. Consequently, a growing segment of the population is turning to these artificial intelligence systems for health‑related decisions, thereby prompting discussions about the legal implications of reliance on technology that functions as a non‑judgmental medical advisor. Observers note that the anonymity and algorithmic nature of these tools may encourage individuals who previously avoided conventional medical consultation due to fear of criticism, thereby expanding the reach of digital health interventions across diverse socioeconomic groups. Nevertheless, the absence of a human clinician’s judgment raises questions concerning the adequacy of clinical oversight, the standards of care applied, and the mechanisms for accountability should the artificial intelligence recommendations result in adverse health outcomes. Furthermore, the integration of personal health data into these AI platforms underscores concerns about data protection, consent, and the potential for unauthorized disclosure or misuse of sensitive medical information. These developments collectively suggest that the emergence of AI as a perceived non‑judgmental doctor is reshaping patient expectations and prompting a need for legal scrutiny of the frameworks governing medical advice, liability, and privacy in the digital era.
One question is whether existing professional negligence principles applicable to medical practitioners can be extended to cover artificial intelligence systems that provide diagnostic or therapeutic recommendations without direct human supervision. The answer may depend on judicial interpretation of the duty of care owed by providers of AI‑driven health services, particularly whether they are deemed to act as de facto medical practitioners under prevailing case law.
Perhaps the more important regulatory issue is whether the statutory framework governing medical practice, which traditionally mandates licensure for human doctors, should be amended to include certification requirements for AI health platforms to ensure compliance with safety standards. A competing view may argue that existing consumer protection statutes already provide sufficient mechanisms to address misleading or harmful AI medical advice, thereby obviating the need for a separate medical‑specific regulatory regime.
Perhaps the constitutional concern centers on the right to privacy, as articulated by the Supreme Court, which may be engaged when AI platforms collect, store, and process sensitive health information without explicit informed consent from users. The legal position would turn on whether existing data protection legislation, such as the Personal Data Protection Bill, imposes obligations on AI health service providers to implement robust safeguards and obtain specific consent for processing medical data.
If an AI recommendation leads to a detrimental health outcome, a plaintiff may seek compensation by alleging negligence, but the court would likely examine the causal link between the algorithmic suggestion and the injury, as well as the foreseeability of harm. Another possible view is that the liability may rest on the entity that deployed the AI system, with responsibility falling under product liability principles if the software is deemed defective or fails to meet established standards of care.
Thus, the surge in patient reliance on AI as a non‑judgmental medical advisor foregrounds a spectrum of legal challenges that demand legislative clarity, judicial guidance, and proactive regulatory action to balance innovation with protection of health rights.
Future judicial determinations may need to address whether the principle of non‑discrimination requires that AI medical tools be accessible to all sections of society without creating a new digital divide that undermines the constitutional guarantee of equality before law. A fuller legal assessment would require clarity on the precise regulatory classification of AI health platforms, the extent of professional oversight required, and the mechanisms through which patients can seek redress when technology fails to meet expected standards.